Background: Patients with heart failure (HF) are at increased risk of unmet palliative care needs. The International Classification of Diseases, Ninth Revision (ICD-9) code, V66.7, can identify palliative care services. However, code validity for specialist palliative care in the Veterans Health Administration (VHA) has not been determined. Objective: To validate the ICD-9 code for specialist palliative care and determine common reasons for specialist palliative care consultation among VHA patients hospitalized with HF. Design: Electronic health record review of data from the Veterans Aging Cohort Study. Setting/Participants: The sample included 100 patients hospitalized with HF from 2003 to 2012. Measurements: Data from 50 patients with V66.7 were matched by age, race, site of care, hospital length of stay, intensive care unit admission, and fiscal year of study discharge to 50 patients with HF without V66.7 who had died within a year of hospitalization. We calculated positive and negative predictive values (PPV, NPV), sensitivity, and specificity. Results: All patients included in the sample were male, 66% black ethnicity, and mean age ¼ 65 years (standard deviations [SD] + 10.5 for cases; SD + 9.8 for matches). Specialist palliative care was documented for 49 of 50 patients with V66.7 (PPV ¼ 98%, 95% confidence interval [CI]: 88-99) and 9 of 50 patients without the code (NPV ¼ 82%, 95% CI: 68-91). Sensitivity was 84% (95% CI: 72-92), and specificity was 98% (95% CI: 86-99). Establishing goals of care was the most frequent reason for palliative care consultation (43% of the sample). Conclusion: The ICD-9 code V66.7 identifies specialist palliative care for hospitalized patients with HF in the VHA. Replication of findings in other data sources and populations is needed.
Introduction
Adults with heart failure (HF) have significant symptom burden, complex medical regimens, frequent hospitalizations and readmissions, and prognostic uncertainty.
1,2 Approximately 20% to 25% of patients with HF are readmitted within 1 month of hospital discharge, and 20% to 40% die within a year of hospitalization. 3, 4 Given the significant morbidity and mortality associated with HF, management guidelines recommend referral to palliative care for patients with advanced disease, including those who are symptomatic despite optimization of guideline-based therapies. 1, 5, 6 However, rates of palliative care delivery for patients with HF during hospitalization vary widely [7] [8] [9] [10] and remain substantially lower than patients with cancer. 11 A recent study of patterns of palliative care delivery among decedents within the Veterans Health Administration (VHA) found that 47% of decedents with cardiopulmonary failure received palliative care within 90 days of death compared to 74% of decedents with cancer. 11 In acute care settings, trained and typically palliativecertified specialists (specialist palliative care) address many of the physical, psychological, existential, and spiritual symptoms patients may have during hospitalization. Specialist palliative care clinicians may also serve as hospice providers, or attend on inpatient palliative care units. Specialist palliative care can be identified by electronic health record (EHR) reviews, use of national palliative care and hospice registries, and administrative databases and claims records. [2] [3] [4] Within administrative databases, researchers often use the International Classification of Diseases, Ninth Revision (ICD-9) diagnosis code V66.7 as a means of identifying palliative care. [12] [13] [14] [15] The ICD-9 code V66.7, "Encounter for Palliative Care," applies to instances in which specialist or nonspecialist clinicians provide palliative, end-of-life, or terminal care services, primarily within inpatient settings. 16 The use of V66.7 for research purposes remains controversial due to concerns over code validity in identifying palliative care. [17] [18] [19] Prior research has found variation in code sensitivity ranging from 45% to 82% in samples including patients with HF. [19] [20] [21] The VHA has instructed that V66.7 be used for palliative care workflow capture since 2002. 22, 23 However, the V66.7 code has not been validated in this health system. Code validation could lead to increased utilization in research aimed at understanding disparities in the use of specialist palliative care among patients with HF within the VHA. Therefore, we validated the ICD-9 code for palliative care, V66.7, using EHR reviews as the reference and determined reasons for specialist palliative care consultations during hospitalization in patients hospitalized with HF.
Methods
Study patients were sampled from the Veterans Aging Cohort Study (VACS). The VACS is an EHR-based cohort of all HIVinfected Veterans engaged in care within the VHA system matched 1:2 with uninfected Veterans by age, race, gender, and site of care. 24 The VACS data sources include EHR, laboratory, pharmacy, and administrative data. 25 Study approval was obtained from the institutional review boards in which the study was conducted.
Sample
Among 7496 patients hospitalized with HF (ICD-9 code 425.x and 428.x) 26 between fiscal years 2003 and 2012, we found 235 patient records that included the ICD-9 code V66.7. We randomly selected 50 of these patients for review, using the first HF hospitalization with code V66.7. From the 7261 patients hospitalized with HF without the V66.7 code, we then identified 2722 patients who had died within 1 year of hospital admission. Using the last hospitalization prior to death, we matched 50 of these patients to those patients with V66.7 by age (+5 years), race, site of care, hospital length of stay (+3 days), intensive care unit (ICU) admission during hospitalization, and fiscal year of study discharge (+3 years). Patients without V66.7 who were still alive 1 year after admission were not included in the analysis. The final sample was 100 patients characterized using both EHR data and manual EHR review.
Procedures and Study Variables
Two authors (S.L.F. and K.M.A.), both clinicians trained in palliative care, reviewed progress notes (EHR note titles and unstructured text), provider consultation notes, discharge summaries, and other clinical data for documentation of palliative care during the hospitalization. Criteria for specialist palliative care included evidence of any of the following: palliative care consultation or follow-up by any palliative care consultation service team member, care in an inpatient palliative care or hospice unit, or care in a nonhospice unit with hospice services. We determined the primary reason for specialist palliative care from palliative care providers' initial consult notes or from admission notes to inpatient palliative care and hospice units documented in the EHR. Primary reasons for specialist palliative care were grouped based on national clinical guidelines 27 into mutually exclusive categories: goals of care, management of physical symptoms, management of psychological symptoms, social services and discharge planning, spiritual care, end-of-life care, and ethical or legal care (including code status discussions). To account for potential overlap among categories, for example, in cases where goals of care conversations include discussions of discharge planning or end-of-life care, reviewers only selected goals of care if the phrase "goals of care" was documented in the specialist palliative care consultation note. Reviewers entered EHR review data using the Research Electronic Data Capture platform, 28 a secure, web-based application designed to support data capture research studies. Inter-rater reliability was determined by review of 31 patients' charts by 2 investigators (S.L.F. and K.M.A.).
Extracted data included demographics, comorbidities, and laboratory tests. The HF diagnosis was classified as principal (primary condition associated with the entire hospitalization), or secondary if the HF code appeared in any other diagnosis fields. To describe the degree of cardiac dysfunction, we collected ejection fraction (EF) measurements from the first measurement during hospitalization, or if unavailable, the lowest measurement within 6 months prior to hospital admission. We assessed comorbidities commonly found in the VACS cohort and those frequently associated with HF. [10] [11] [12] [13] [14] [15] Comorbidities were identified by 1 inpatient or 2 outpatient ICD-9 codes for the condition within 30 days of the index admission, a previously established approach that improves coding accuracy compared to using a single instance. 25 We included acute renal failure, anemia, chronic renal failure, chronic obstructive pulmonary disease (COPD), coronary artery disease, depression, diabetes mellitus, drug abuse, and hypertension. We identified diabetes mellitus by the ICD-9 code or by evidence of serum glucose meeting diagnostic criteria for diabetes mellitus. 24, 25 Hepatitis C and HIV infection were determined by a combination of ICD-9 codes, positive antibody tests, or detectable plasma HCV-RNA or HIV-1 RNA, respectively. Comorbidities present in more than 25% of the sample were included in the analysis.
To measure severity of illness, we used the VACS index, a validated risk score of HIV-specific and general organ injury that predicts all-cause mortality, medical ICU (MICU) admission, and MICU mortality among HIV-infected and uninfected adults. [29] [30] [31] The VACS index variables include age, CD4 cell count, HIV-1 RNA, hemoglobin, liver transaminases, aspartate transanimase, alanine transaminase, platelets, creatinine, and Hepatitis C virus coinfection. Higher scores are associated with increased hospital and long-term mortality. 32 The VACS index was calculated for those patients with complete lab values on the first day of hospital admission or within 6 months prior to hospitalization using the values closest to admission.
Statistical Analysis
We assessed the ability of ICD-9 code V66.7 to identify specialist palliative care using EHR documentation as the reference standard. We calculated positive and negative predictive values (PPV, NPV), sensitivity, and specificity. We assessed inter-rater reliability with the k statistic to determine agreement between reviewers regarding palliative care documentation within the EHR. Statistical significance was defined as a P value of <.05. We performed statistical analysis with SAS 9.4 (SAS Institute, Cary, North Carolina).
Results
The sample was 100% male, and the mean age was 64.62 (standard deviation [SD] 10.51) years for patients with V66.7 and 64.81 (SD 9.82) years for the comparison group (Table 1) . The sample was racially and ethnically diverse (66% black; 24% white; 10% Hispanic), reflecting characteristics consistent with VACS overall. 24, 25 Heart failure was the principal diagnosis for 36% of patients with V66.7 and 22% among the comparison group (P ¼ .21). Ejection fraction measurements were available for 50% of patients with V66. 7 Validation of the ICD-9 V66.7 Palliative Care Code Specialist palliative care was documented for 49 of 50 (PPV 98%, 95% confidence interval [CI]: 88-99) patients whose records included V66.7 and for 9 of 50 (NPV 82%, 95% CI: 68-91) patients without the code ( Table 2 ). The sensitivity of the ICD code for specialist palliative care was 84% (95% CI: 72-92), and specificity was 98% (95% CI: 86-99). One patient with code V66.7 did not have documented evidence of specialist palliative care and was discharged alive to home without additional services such as home hospice. The k statistic for inter-rater reliability between reviewers for documentation of specialist palliative care was 1.0, reflecting 100% agreement. 
Primary Reason for Specialist Palliative Care
Of the total sample, 58 patients had documented evidence of specialist palliative care. Ninety-one percent of patients who had documented evidence of specialist palliative care (n ¼ 53) were seen by a palliative care consultation service (Table 1) . Primary reasons for specialist palliative care included establishing goals of care (43%), end-of-life care (21%), and the management of physical symptoms including pain (17%; Figure 1 ).
Discussion
To our knowledge, our study represents for the first time, the V66.7 code has been validated within the VHA. We found the V66.7 code to have higher sensitivity but similar specificity (sensitivity 84% and specificity 98%) compared to other validation studies inclusive of patients with and without HF. 23, 25 For example, prior work has identified V66.7 validity in capturing withdrawal of life-sustaining therapies of patients with acute ischemic stroke at 2 teaching hospitals (sensitivity 81% and specificity 97%). 21 Another single-center study found that the V66.7 code had a sensitivity of 50% and specificity of 99% for specialist palliative care for all hospitalized patients. 19 In analyses restricted to patients with HF, performance of the code decreased considerably, with a sensitivity of 45% and a specificity of 98%. In a larger study of patients with cancer, HF, and COPD from 33 hospitals involved in the University HealthSystem Consortium, V66.7 coding and documentation were infrequent among patients who received specialist palliative care, with only 48% of those receiving palliative care noted to have a documented V66.7 code in the EHR. 20 There are likely several explanations for the variation in code validity found in our study compared with prior work. First, differences in code sensitivity may reflect variations in billing and coding practices across health systems as well as the coding input for their respective administrative data sets. The VHA instructed that the ICD-9 code for palliative care be used for palliative care workflow capture in a nationwide directive starting in 2002 and reinstituted the directive in 2008. 22, 23 Consistent billing and coding practices across all VHA health centers, clinicians, and hospital coders could lead to increased application of the ICD-9 code. Our study findings may also reflect the VHA's emphasis on increasing patient access to palliative care, as the VHA directed that inpatient facilities provide palliative care consultative services starting in 2003. 23, 33 Second, code validity may vary based on who delivers palliative care and by the specific characteristics of palliative care delivery. For this study, we chose not to validate the utility of the code in capturing primary palliative care, that is, palliative care delivered by nonpalliative specialists during hospitalization, or in identifying specific processes of palliative care, such as withdrawal of life-sustaining treatments, symptom management, or discussions of goals of care. Primary palliative care may more likely be documented in unstructured text fields of patient progress notes and nursing notes rather than note titles and discharge summaries, potentially making recognition by medical coders difficult. 22 Of these palliative care characteristics, others have validated the code's ability to capture withdrawal of care, 21 but validation of the ICD-9 code's ability to capture other processes of palliative care such as symptom management or represent primary palliative care delivery is not known.
A strength of the study is in the use of a large nationwide sample of hospitalized patients with HF from the VHA. However, this study has several limitations. Although patients were matched on several demographic and clinical variables, we could not control for unmeasured differences. In addition, other matching criteria or methods such as propensity score matching may have also yielded well-matched groups. Although we did not have data on such variables as the New York Heart Association functional class or complete EF data, our analysis revealed no differences between groups in terms of a principal hospital diagnosis of HF and the VACS risk score, which suggests that both groups were likely similar in terms of disease severity.
Our validation findings are based on the assumption that specialist palliative care provided during hospitalization was documented in the EHR. Palliative care provided but not documented would bias our results, potentially underrepresenting the receipt of palliative care. However, this limitation applies to any study using data other than direct observation for analysis. There may also be differences in case mix between VHA and non-VHA hospitals regarding the availability of palliative care services, provider preferences in referral to palliative care, and patient populations. Our study sample was comprised only of men with HF, who were younger than other research cohorts of patients with HF receiving palliative care. 7, 8 This, in addition to the small sample size, may limit the generalizability of study findings. The prevalence of palliative care in this study was 50% by study design. The PPV could be lower in other samples where the prevalence of specialist palliative care is lower than 50%. A final caveat is that we validated the ICD-9 diagnosis code for palliative care rather than the International Classification of Diseases, Tenth Revision (ICD-10) iteration, z51.5. However, the ICD-9 diagnosis code V66.7 converts directly to z51.5 in ICD-10 and is considered an equivalent of the ICD-9 version. 34 Our findings have several implications for future research. In the creation of our study sample, we found that 235 (3.1%) patients out of 7496 patients hospitalized with HF during the study period had an ICD-9 code for palliative care. The percentage of patients with HF who had the ICD-9 diagnostic code is lower than the estimated 6% of all hospital discharges palliative care could potentially serve. 35 This may suggest underutilization of palliative care for hospitalized patients with HF; however additional research is needed.
Future work should examine the validity of the ICD-9 V66.7 code in other EHR systems with different patient populations and conditions, using other study designs and matching methods. Coding algorithms that include V66.7 in addition to other ICD-9 codes may facilitate further validation of the V66.7 code and allow for the identification of palliative care among multiple data sources. Over 28% of patients with V66.7 and 48% of matches were HIV infected. HIV-infected patients with HF have less access to advanced HF therapies including heart transplants and left ventricular assist devices compared to patients with HF who are uninfected. 36, 37 Differences in referral to palliative care and coding of palliative care services by HIV status should also be investigated. Alternative measurement solutions for palliative care that capture specialist palliative care, primary palliative care, and processes of palliative care are also needed. 27 The use of informatics-based techniques, such as text mining, may facilitate data retrieval of palliative care and palliative care processes from unstructured text. These methods could also identify palliative care delivered by a variety of clinicians, perhaps providing a more comprehensive depiction of palliative care service delivery.
Conclusion
In a sample of patients hospitalized with HF, we found that the predictive values and sensitivity of the palliative care diagnosis code V66.7 in capturing specialist palliative care were high. The diagnosis code for palliative care is likely accurate in identifying specialist palliative care for patients hospitalized with HF in the VHA. Replication of findings in other data sources is warranted; however, future work should also seek to identify alternative techniques that can capture primary palliative care and processes of palliative care.
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